AU2002222118A1 - Pharmaceutical compositions for inhalation - Google Patents

Pharmaceutical compositions for inhalation

Info

Publication number
AU2002222118A1
AU2002222118A1 AU2002222118A AU2211802A AU2002222118A1 AU 2002222118 A1 AU2002222118 A1 AU 2002222118A1 AU 2002222118 A AU2002222118 A AU 2002222118A AU 2211802 A AU2211802 A AU 2211802A AU 2002222118 A1 AU2002222118 A1 AU 2002222118A1
Authority
AU
Australia
Prior art keywords
inhalation
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222118A
Inventor
Robin Bannister
Haggis Harris
David Alexander Vodden Morton
John Nicholas Staniforth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura Ltd
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27447911&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002222118(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0029261A external-priority patent/GB0029261D0/en
Priority claimed from GB0030946A external-priority patent/GB0030946D0/en
Priority claimed from PCT/GB2001/001606 external-priority patent/WO2001076575A2/en
Priority claimed from GB0124010A external-priority patent/GB0124010D0/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of AU2002222118A1 publication Critical patent/AU2002222118A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002222118A 2000-11-30 2001-11-30 Pharmaceutical compositions for inhalation Abandoned AU2002222118A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0029261A GB0029261D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
GB0029261.5 2000-11-30
GB0030946A GB0030946D0 (en) 2000-12-19 2000-12-19 Method of making particles for use in a pharmaceutical composition
GB0030946.8 2000-12-19
PCT/GB2001/001606 WO2001076575A2 (en) 2000-04-07 2001-04-09 The treatment of respiratory diseases
AUPCT/GB2001/001606 2001-04-09
GB0124010A GB0124010D0 (en) 2001-10-05 2001-10-05 Pharmaceutical compositions for inhalation
GB0124010.0 2001-10-05
PCT/GB2001/005334 WO2002043702A2 (en) 2000-11-30 2001-11-30 Pharmaceutical compositions for inhalation

Publications (1)

Publication Number Publication Date
AU2002222118A1 true AU2002222118A1 (en) 2002-06-11

Family

ID=27447911

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2211502A Pending AU2211502A (en) 2000-11-30 2001-11-30 Method of making particles for use in a pharmaceutical composition
AU2002222115A Expired AU2002222115B2 (en) 2000-11-30 2001-11-30 Method of making particles for use in a pharmaceutical composition
AU2002222118A Abandoned AU2002222118A1 (en) 2000-11-30 2001-11-30 Pharmaceutical compositions for inhalation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2211502A Pending AU2211502A (en) 2000-11-30 2001-11-30 Method of making particles for use in a pharmaceutical composition
AU2002222115A Expired AU2002222115B2 (en) 2000-11-30 2001-11-30 Method of making particles for use in a pharmaceutical composition

Country Status (10)

Country Link
EP (2) EP1337240B2 (en)
JP (1) JP4380988B2 (en)
AU (3) AU2211502A (en)
CA (1) CA2429665C (en)
CY (2) CY1117749T1 (en)
DE (1) DE60132239T2 (en)
DK (1) DK2283818T3 (en)
ES (1) ES2296831T3 (en)
NZ (1) NZ526059A (en)
WO (2) WO2002043701A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
RO121172B1 (en) * 2001-03-30 2007-01-30 Jago Research Ag Aerosol pharmaceutical composition and use thereof
GB0208742D0 (en) * 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
IL160570A0 (en) 2001-09-26 2004-07-25 Baxter Int Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
EP1480691A4 (en) * 2002-03-05 2007-11-28 Univ State Cleveland Agglomerated particles for aerosol drug delivery
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
CN102688224A (en) * 2003-04-14 2012-09-26 维克特拉有限公司 Device and pharmaceutical composition enhancing administration efficiency
JP2006522634A (en) 2003-04-14 2006-10-05 ベクトゥラ・リミテッド Device and pharmaceutical composition for improving administration efficiency
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
NZ545484A (en) * 2003-09-15 2009-09-25 Vectura Ltd Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
GB0321607D0 (en) 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
WO2005077339A1 (en) * 2004-02-10 2005-08-25 E.I. Dupont De Nemours And Company Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister
GB0409703D0 (en) * 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
GB0410399D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0418791D0 (en) * 2004-08-23 2004-09-22 Glaxo Group Ltd Novel process
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
WO2006076191A2 (en) * 2005-01-10 2006-07-20 Elc Management Llc Discontinuous surface coating for particles
AU2006278571B2 (en) * 2005-08-05 2011-11-24 3M Innovative Properties Company Compositions exhibiting improved flowability
GB0525254D0 (en) 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
GB0613161D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
DK2435024T3 (en) * 2009-05-29 2016-10-24 Pearl Therapeutics Inc Compositions for the respiratory delivery of active agents and related methods and systems
DE102009049470A1 (en) * 2009-10-15 2011-04-28 Süd-Chemie AG Process for the preparation of finely divided lithium titanium spinels and their use
GB0921481D0 (en) 2009-12-08 2010-01-20 Vectura Ltd Process and product
KR20120104235A (en) * 2009-12-14 2012-09-20 키에시 파르마슈티시 엣스. 피. 에이. Antibiotic microparticles for inhalation
EP2552424B1 (en) * 2010-04-01 2018-05-09 Chiesi Farmaceutici S.p.A. Process for preparing carrier particles for dry powders for inhalation
ITUD20100112A1 (en) 2010-06-09 2011-12-10 Farma Derma S R L PREPARATION FOR VAGINAL AND RECTAL USE AND ITS PRODUCTION PROCEDURE
TW201304822A (en) 2010-11-15 2013-02-01 Vectura Ltd Compositions and uses
WO2012073025A1 (en) 2010-11-30 2012-06-07 Vectura Limited Glucosaminoglucans such as heparin for use in the treatment of pulmonary inflammation such as copd
US9763965B2 (en) 2012-04-13 2017-09-19 Glaxosmithkline Intellectual Property Development Limited Aggregate particles
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
EP2957552B1 (en) 2014-06-16 2020-01-22 Arven Ilac Sanayi Ve Ticaret A.S. Vilanterol formulations
TR201407010A2 (en) 2014-06-16 2015-12-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Vilanterol formulations.
MX2017003080A (en) * 2014-09-09 2017-11-15 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus.
MX2017005692A (en) 2014-10-31 2017-08-07 Glaxosmithkline Ip Dev Ltd Powder formulation.
JP6732750B2 (en) * 2014-12-17 2020-07-29 ロレアル Composite particles and their preparation
US20210353650A1 (en) * 2020-05-18 2021-11-18 Cai Gu Huang Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (en) † 1986-03-04 1989-03-10 Chiesi Farma Spa INHALATION PHARMACEUTICAL COMPOSITIONS
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Pharmaceutical preparations from coated, poorly water-soluble pharmaceutical substances for inhalation pharmaceutical forms and processes for their preparation
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
HUT77775A (en) * 1994-12-22 1998-08-28 Astra Aktiebolag Aerosol drug formulations
GB9501841D0 (en) † 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
ES2189410T3 (en) † 1998-04-18 2003-07-01 Glaxo Group Ltd PHARMACEUTICAL FORMULATION IN AEROSOL.
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
CA2347856C (en) † 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
GB9827145D0 (en) † 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
HUP0200185A3 (en) † 1999-03-05 2006-07-28 Chiesi Farma Spa Improved powdery pharmaceutical compositions for inhalation
PE20011227A1 (en) † 2000-04-17 2002-01-07 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES
PT1337239E (en) † 2000-11-30 2010-01-26 Vectura Ltd Particles for use in a pharmaceutical composition

Also Published As

Publication number Publication date
EP1337241B1 (en) 2008-01-02
CA2429665A1 (en) 2002-06-06
AU2002222115B2 (en) 2006-09-28
EP1337240B2 (en) 2014-09-24
WO2002043702A2 (en) 2002-06-06
ES2296831T3 (en) 2008-05-01
CA2429665C (en) 2013-10-22
CY1117749T1 (en) 2017-05-17
AU2211502A (en) 2002-06-11
DE60132239D1 (en) 2008-02-14
WO2002043702A3 (en) 2002-10-17
WO2002043701A3 (en) 2002-10-17
EP1337240A2 (en) 2003-08-27
NZ526059A (en) 2005-05-27
EP1337241A2 (en) 2003-08-27
WO2002043701A2 (en) 2002-06-06
EP1337240B1 (en) 2011-07-27
JP4380988B2 (en) 2009-12-09
CY1119400T1 (en) 2018-02-14
DE60132239T2 (en) 2008-05-08
JP2004514504A (en) 2004-05-20
DK2283818T3 (en) 2017-10-16

Similar Documents

Publication Publication Date Title
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002313236A1 (en) Medicinal compositions
AU6219601A (en) Pharmaceutical compositions
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002302147A1 (en) Pharmaceutical composition
AU2002214324A1 (en) Medicinal compositions
AU2002258221A1 (en) Medicinal composition
AU8576801A (en) Pharmaceutical compositions
AU2001290239A1 (en) Medicinal composition
AU1390002A (en) Pharmaceutical compositions
AU2001273919A1 (en) Pharmaceutical compositions
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU4085201A (en) Pharmaceutical composition
AU2002354460A1 (en) Medicinal composition
AU4853101A (en) Respiratory compositions
AU2001278705A1 (en) Pharmaceutical composition
AU3586401A (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions
AUPR529701A0 (en) Pharmaceutical composition
AU2001285737A1 (en) Pharmaceutical compositions
AU2002346223A1 (en) Medicinal compositions